Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

PathoGenesis licenses Cystic Fibrosis Foundation's tobramycin

Executive Summary

The Cystic Fibrosis Foundation and Seattle's Children's Hospital and Medical Center licensed PathoGenesis Corp. exclusive worldwide rights to TOBI, an aerosolized (not injected) tobramycin solution for treating bronchopulmonary infections.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Contract
    • R&D and Marketing (Licensing)

Related Companies